InVivo Therapeutics Holdings Price to Book Ratio 2012-2023 | NVIVQ
Historical price to book ratio values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years. The current price to book ratio for InVivo Therapeutics Holdings as of June 22, 2026 is 0.00.
| InVivo Therapeutics Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-07-19 | 0.37 | 0.13 | |
| 2023-09-30 | 1.12 | $2.87 | 0.39 |
| 2023-06-30 | 1.35 | $3.73 | 0.36 |
| 2023-03-31 | 1.06 | $4.34 | 0.24 |
| 2022-12-31 | 2.35 | $6.48 | 0.36 |
| 2022-09-30 | 4.29 | $7.26 | 0.59 |
| 2022-06-30 | 4.05 | $9.21 | 0.44 |
| 2022-03-31 | 8.75 | $11.32 | 0.77 |
| 2021-12-31 | 11.50 | $13.21 | 0.87 |
| 2021-09-30 | 17.50 | $15.28 | 1.15 |
| 2021-06-30 | 18.50 | $17.01 | 1.09 |
| 2021-03-31 | 24.75 | $18.62 | 1.33 |
| 2020-12-31 | 20.25 | $20.30 | 1.00 |
| 2020-09-30 | 35.50 | $39.98 | 0.89 |
| 2020-06-30 | 39.50 | $51.36 | 0.77 |
| 2020-03-31 | 42.25 | $92.92 | 0.45 |
| 2019-12-31 | 165.00 | $253.31 | 0.65 |
| 2019-09-30 | 375.00 | $619.61 | 0.61 |
| 2019-06-30 | 555.00 | $843.95 | 0.66 |
| 2019-03-31 | 1162.50 | $1,092.06 | 1.06 |
| 2018-12-31 | 1132.50 | $1,299.27 | 0.87 |
| 2018-09-30 | 1515.00 | $1,631.05 | 0.93 |
| 2018-06-30 | 1275.00 | $-351.44 | -3.63 |
| 2018-03-31 | 10125.00 | $4,000.32 | 2.53 |
| 2017-12-31 | 14437.50 | $7.38 | 1955.88 |
| 2017-09-30 | 27187.50 | $0.42 | 65244.78 |
| 2017-06-30 | 50625.00 | $0.59 | 85790.54 |
| 2017-03-31 | 75937.50 | $0.75 | 101670.24 |
| 2016-12-31 | 78750.00 | $0.90 | 87083.93 |
| 2016-09-30 | 127500.00 | $1.03 | 124244.79 |
| 2016-06-30 | 108375.00 | $1.18 | 91874.36 |
| 2016-03-31 | 130875.00 | $1.30 | 100526.15 |
| 2015-12-31 | 135000.00 | $0.62 | 219512.20 |
| 2015-09-30 | 161625.00 | $0.63 | 255857.21 |
| 2015-06-30 | 302812.00 | $0.59 | 513851.18 |
| 2015-03-31 | 222750.00 | $0.39 | 564209.73 |
| 2014-12-31 | 99000.00 | $0.25 | 391923.99 |
| 2014-09-30 | 42000.00 | $0.15 | 289655.17 |
| 2014-06-30 | 78000.00 | $0.15 | 519307.59 |
| 2014-03-31 | 132000.00 | $0.11 | 1149825.78 |
| 2013-12-31 | 172500.00 | $0.16 | 1053113.55 |
| 2013-09-30 | 107250.00 | $0.22 | 479436.75 |
| 2013-06-30 | 309750.00 | $0.29 | 1085318.85 |
| 2013-03-31 | 179250.00 | $-0.22 | -826798.89 |
| 2012-12-31 | 130500.00 | $-0.04 | -3717948.72 |
| 2012-09-30 | 116250.00 | $0.08 | 1388888.89 |
| 2012-06-30 | 171750.00 | $-0.07 | -2349521.20 |
| 2012-03-31 | 186000.00 | $-0.13 | -1404833.84 |
| 2011-12-31 | 206250.00 | $-0.58 | -355480.87 |
| 2011-09-30 | 49500.00 | $-0.01 | -4342105.26 |
| 2011-06-30 | 74250.00 | $-0.08 | -978260.87 |
| 2011-03-31 | 63750.00 | $-0.06 | -1089743.59 |
| 2010-12-31 | 168750.00 | $-0.04 | -4700557.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $152.983B | 16.86 |
| Stryker (SYK) | United States | $116.806B | 22.75 |
| Medtronic (MDT) | Ireland | $101.469B | 14.34 |
| EssilorLuxottica (ESLOY) | France | $89.470B | 0.00 |
| Boston Scientific (BSX) | United States | $65.890B | 14.30 |
| Medline (MDLN) | United States | $45.598B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.521B | 0.00 |
| Agilent Technologies (A) | United States | $35.725B | 21.77 |
| GE HealthCare Technologies (GEHC) | United States | $27.585B | 13.30 |
| ResMed (RMD) | United States | $27.336B | 17.50 |
| Koninklijke Philips (PHG) | Netherlands | $26.518B | 15.42 |
| Terumo (TRUMY) | Japan | $20.489B | 22.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $16.849B | 10.27 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.494B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.510B | 0.00 |
| Baxter (BAX) | United States | $10.154B | 9.45 |
| Insulet (PODD) | United States | $9.626B | 25.83 |
| Demant (WILYY) | Denmark | $8.153B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.523B | 30.33 |
| Lantheus Holdings (LNTH) | United States | $6.914B | 21.33 |
| BillionToOne (BLLN) | United States | $4.633B | 0.00 |
| Envista Holdings (NVST) | United States | $4.151B | 19.33 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.062B | 0.00 |
| ICU Medical (ICUI) | United States | $3.403B | 21.44 |
| Haemonetics (HAE) | United States | $3.296B | 14.59 |
| Curaleaf Holdings (CURLD) | Canada | $2.248B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.154B | 10.35 |
| GN Store Nord (GNNDY) | Denmark | $2.053B | 97.19 |
| LeMaitre Vascular (LMAT) | United States | $2.025B | 34.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.951B | 0.00 |
| Neogen (NEOG) | United States | $1.942B | 42.48 |
| Capricor Therapeutics (CAPR) | United States | $1.699B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.522B | 16.27 |
| AtriCure (ATRC) | United States | $1.440B | 948.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.328B | 3.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 33.31 |
| Phibro Animal Health (PAHC) | United States | $1.260B | 10.60 |
| BioLife Solutions (BLFS) | United States | $1.217B | 207.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.210B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.912B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.844B | 9.23 |
| InMode (INMD) | Israel | $0.759B | 9.57 |
| Omeros (OMER) | United States | $0.748B | 4.74 |
| CeriBell (CBLL) | United States | $0.690B | 0.00 |
| Brainsway (BWAY) | Israel | $0.577B | 41.09 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Cerus (CERS) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.508B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.472B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.438B | 10.95 |
| Evolus (EOLS) | United States | $0.434B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.417B | 29.38 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.392B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.360B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 17.46 |
| MacroGenics (MGNX) | United States | $0.291B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Accendra Health (ACH) | United States | $0.245B | 4.71 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Village Farms (VFF) | Canada | $0.214B | 8.50 |
| Utah Medical Products (UTMD) | United States | $0.211B | 19.57 |
| High Tide (HITI) | Canada | $0.201B | 57.25 |
| Sanara MedTech (SMTI) | United States | $0.199B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.198B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.176B | 47.83 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quanterix (QTRX) | United States | $0.164B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.164B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.102B | 13.71 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| ImmuCell (ICCC) | United States | $0.088B | 0.00 |
| Biote (BTMD) | United States | $0.085B | 5.11 |
| Hongchang (HCIL) | China | $0.081B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.077B | 27.30 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.035B | 46.57 |
| United-Guardian (UG) | United States | $0.032B | 13.46 |
| Rockwell Medical (RMTI) | United States | $0.026B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.026B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Jin Medical (ZJYL) | China | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Akanda (AKAN) | Canada | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| INLIF (INLF) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |